Author

Daniel Sungchul Choi

Observed names: DC Choi, Daniel C Choi, Daniel C. Choi, Daniel Chimin Choi, Daniel Choi, Daniel S. Choi

Observed institutions: Albert Einstein College of Medicine, Montefiore Medical Center, NewYork–Presbyterian Hospital, Harvard University, Cornell University, Dana-Farber Cancer Institute, Weill Cornell Medicine, Tisch Cancer Institute, Weill Cornell Medical Center, Icahn School of Medicine at Mount Sinai

ORCID: 0000-0003-3406-9113

Observed ORCID: 0000-0003-3406-9113

OpenAlex ID: A5065834595

A Fluoride-Derived Electrophilic Late-Stage Fluorination Reagent for PET Imaging

2011 · Eunsung Lee, Adam S. Kamlet, et al. · Science · 433

Mapping genotypes to chromatin accessibility profiles in single cells

2024 · Franco Izzo, Robert M. Myers, et al. · Nature · 67

PDF

Activation of the Mitochondrial Fragmentation Protein DRP1 Correlates with BRAFV600E Melanoma

2015 · Shira Y. Wieder, Madhavika N. Serasinghe, et al. · Journal of Investigative Dermatology · 63

Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms

2017 · DC Choi, D Tremblay, et al. · Annals of Hematology · 23

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

2025 · James T. Yoon, Yinglu Zhou, et al. · Blood Advances · 16

PDF

Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome

2022 · Ghaith Abu-Zeinah, Silvana Di Giandomenico, et al. · Blood Advances · 15

PDF

JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms

2024 · Daniel C. Choi, Nassima Messali, et al. · Leukemia · 14

PDF

Type 1 interferon perturbates clonal competition by reshaping human blood development

2026 · Chhiring Lama, Danielle Isakov, et al. · Nature Genetics · 5

JAK2 V617F Impairs T Cell Differentiation in Polycythemia Vera

2022 · Daniel C Choi, Ghaith Abu-Zeinah, et al. · Blood · 4

JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms

2023 · Daniel C Choi, Ghaith Abu-Zeinah, et al. · Blood · 3

PDF

Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

2022 · Lindsay M. Gurska, Rachel Okabe, et al. · Clinical Cancer Research · 3

PDF

61 Functional characterization of ribosomal RNA methyltransferase NSUN5 in glioblastoma

2018 · Jiesi Zhou, Krista Vincent, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 3

PDF

Real-World Assessment of Prophylactic Anakinra on Neurotoxicity and Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory B-Cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis

2026 · Neela Easton, Mia Andreoli, et al. · Transplantation and Cellular Therapy · 2

A phase 1b trial of the EZH2 inhibitor tazemetostat combined with CAR T cell therapy in B cell lymphomas

2025 · Samuel Yamshon, Caitlin Gribbin, et al. · Blood · 2

PDF

Real-world assessment of prophylactic anakinra on neurotoxicity after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis

2025 · Neela Easwar, Mia Andreoli, et al. · Blood · 1

Hematopoietic Bias Drives Lymphopenia in Myeloproliferative Neoplasms

2024 · Daniel C Choi, Nassima Messali, et al. · Blood · 1

PDF

Low Variant Allele Frequency (VAF) TP53 Mutation (mut) Is Not a Poor Prognostic Marker in CLL Patients Treated with Targeted Therapy

2024 · Daniel Sungchul Choi, Yue Ren, et al. · Blood · 1

Polycythemia Vera Patients with >20% Reduction in Whole Blood JAK2V617F Allele Frequency Have Improved Myelofibrosis-Free Survival but Not Overall Survival

2022 · Ghaith Abu-Zeinah, Franco Castillo Tokumori, et al. · Blood · 1

Hematopoietic Stem and Progenitor Cell Fitness As a Novel Prognostic and Monitoring Biomarker for JAK2 V617F Myeloproliferative Neoplasms (MPNs)

2021 · Ghaith Abu-Zeinah, Silvana Di Giandomenico, et al. · Blood · 1

RON Kinase Is a Novel Therapeutic Target for Philadelphia-Negative Myeloproliferative Neoplasms

2021 · Lindsay Meg Gurska, Rachel Okabe, et al. · Blood · 1

Hematology Consultations during the COVID-19 Pandemic at a University Medical Center

2020 · Daniel C Choi, Madhav Seshadri, et al. · Blood · 1

Extensive Intracardiac and Deep Venous Thromboses in a Young Woman with Heparin-Induced Thrombocytopenia and May-Thurner Syndrome

2017 · Yekaterina Kim, Daniel C. Choi, et al. · Case Reports in Hematology · 1

PDF

Immune priming with the EZH2 inhibitor tazemetostat in B-cell lymphomas receiving CAR T-cell therapy.

2026 · Samuel Yamshon, Caitlin Gribbin, et al. · Journal of Clinical Oncology

Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

2025 · Lindsay M. Gurska, Rachel Okabe, et al.

Supplementary Figures1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

2025 · Lindsay M. Gurska, Rachel Okabe, et al.

PDF

Works count: 42

Citation count: 661

H-index: 7

I10-index: 7